ProCE Banner Activity


Strategies for Pharmacists to Overcome Current Challenges and Integrate Novel Maintenance Therapies for the Management of COPD

Text Module

Chronic obstructive pulmonary disease is a leading cause of morbidity and mortality, with many patients struggling to attain the necessary therapies to gain control over their condition. Learn about strategies for integrating novel maintenance therapies, the most recent updates in GOLD guidelines, and ways to facilitate medication access and adherence to improve patient outcomes.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: January 29, 2024

Expiration: January 28, 2025



J. Andrew Woods

J. Andrew Woods, PharmD, BCPS

Professor and Chair
Department of Translational Science and Inpatient Practice
Wingate University School of Pharmacy
Wingate, North Carolina

Provided by

Provided by ProCE, LLC

ProCE Banner


This program is supported in part by an independent medical educational grant from Mylan Specialty L.P., a Viatris Company and Theravance Biopharma Inc.

Mylan Specialty L.P., a Viatris Company

Theravance Biopharma Inc.

Target Audience

The proposed educational program is intended for pharmacists who care for patients with COPD.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of pharmacists in the management of COPD through guideline-directed care, inhalation device selection, and strategies to overcome barriers and optimize patient care.

Learning Objectives

  • Assess the most recent GOLD guideline updates and their impact on selection of maintenance therapy in COPD

  • Formulate individualized treatment plans for COPD maintenance therapy based on efficacy and safety evidence, current guidelines, and patient-related and disease-related factors, including choice of inhalation device

  • Identify strategies to address barriers to optimal outcomes, including disease progression, adherence, access to care, and disparities


ProCE, LLC (ProCE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

J. Andrew Woods, PharmD, BCPS

Professor and Chair
Department of Translational Science and Inpatient Practice
Wingate University School of Pharmacy
Wingate, North Carolina

J. Andrew Woods, PharmD, BCPS: consultant/advisor/speaker: Boehringer Ingelheim.

The planners and content peer reviewers from ProCE, LLC, do not have any relevant financial relationships. to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from January 29, 2024, through January 28, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.



ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-24-003-H01-P has been assigned to this home study application-based activity. This activity is approved for 1.0 contact hour (0.10 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65% or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.